Report overview
This report aims to provide a comprehensive presentation of the global market for Non-Small Cell Lung Cancer Treatment (NSCLC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Small Cell Lung Cancer Treatment (NSCLC). This report contains market size and forecasts of Non-Small Cell Lung Cancer Treatment (NSCLC) in global, including the following market information:
Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Non-Small Cell Lung Cancer Treatment (NSCLC) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Angiogenesis Inhibitor Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non-Small Cell Lung Cancer Treatment (NSCLC) include AbbVie Inc., Astellas Pharma, AstraZeneca, Avid Bioservices Inc., Bayer Healthcare, Biogen Inc., Blueprint Medicines Corp, Eli Lilly and Company and Merck & co Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Non-Small Cell Lung Cancer Treatment (NSCLC) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Segment Percentages, by Type, 2022 (%)
Angiogenesis Inhibitor
Epidermal Growth Factor Receptor Blocker
Kinase Inhibitor
Microtubule Stabilizer
Folate Antimetabolites
Others
Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Segment Percentages, by Application, 2022 (%)
Adenocarcinoma
Squamous Cell Carcinoma
Large Cell Carcinoma
Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Small Cell Lung Cancer Treatment (NSCLC) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Non-Small Cell Lung Cancer Treatment (NSCLC) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc.
Astellas Pharma
AstraZeneca
Avid Bioservices Inc.
Bayer Healthcare
Biogen Inc.
Blueprint Medicines Corp
Eli Lilly and Company
Merck & co Inc.
Novartis
Pfizer Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-Small Cell Lung Cancer Treatment (NSCLC), market overview.
Chapter 2: Global Non-Small Cell Lung Cancer Treatment (NSCLC) market size in revenue.
Chapter 3: Detailed analysis of Non-Small Cell Lung Cancer Treatment (NSCLC) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-Small Cell Lung Cancer Treatment (NSCLC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
